Abstract:Treatment of life-threatening cryptococcal meningitis (CM) is highly challenging due to the limited efficacy of the available antifungal drugs. Antidepressant sertraline (SER) has been proposed to be a potential antifungal agent for CM. However, clinical studies indicated that SER failed to achieve the expected therapeutic effects. Herein, novel SER derivatives were designed by scaffold hopping, and they showed improved anticryptococcal activity both in vitro and in vivo. In particular, compound D16 was identified as a promising anti-CM agent with a new antifungal mode of action. It acted by blocking the biosynthesis of ergosterol through the inhibition of Δ5,6-desaturase. This study provides a new target and a drug-like candidate for CM treatment.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01845.Antifungal activity of compound D16 against 50 strains of Cryptococcus; MFC/MIC ratios of compound D16, SER, and AmB; BBB penetration in the PAMPA-BBB assay of FLC, SER, and compound D16; experimental procedure of the cytotoxicity assay; changes of the ergosterol content of C. neoformans H99 treated with different concentrations of FLC and amorolfine; comparison of sterol components of C. neoformans H99 treated with FLC, SER, and amorolfine at 2 μg/mL; sequences of primers in the RT-PCR assay; sources of strains; structural characterization of intermediates and target compounds; and HPLC spectra of compound D16 (PDF)Molecular formula strings of the target compounds (CSV)This article has not yet been cited by other publications.

Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents.

Discovery of Novel Simplified Sampangine Derivatives with Potent Antifungal Activities against Cryptococcal Meningitis.

Discovery of New Tricyclic Oxime Sampangine Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcosis and Candidiasis

Discovery of Simplified Sampangine Derivatives As Novel Fungal Biofilm Inhibitors.

Discovery of Novel 7-Hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide Derivatives with Potent and Selective Antifungal Activity against Cryptococcus Species

Scaffold Hopping of Sampangine: Discovery of Potent Antifungal Lead Compound Against Aspergillus Fumigatus and Cryptococcus Neoformans.

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

Discovery of novel triazoles containing benzyloxy phenyl isoxazole side chain with potent and broad-spectrum antifungal activity

Discovery of Carboline Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcal Meningitis.

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Structure-based design, synthesis, and antifungal activity of new triazole derivatives.

Discovery of Novel Sertraline Derivatives as Potent Anti- Cryptococcus Agents

Discovery of Novel Isothiazole, 1,2,3-Thiadiazole and Thiazole Based Cinnamamides as Fungicidal Candiate.

Synthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents

Discovery of Highly Potent Triazole Antifungal Derivatives by Heterocycle-Benzene Bioisosteric Replacement

Discovery of novel purinylthiazolylethanone derivatives as anti-Candida albicans agents through possible multifaceted mechanisms

Discovery of highly potent triazoleantifungal agents with piperidine-oxadiazole side chains

Design, synthesis and <i>in vitro</i> biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.

Molecular Docking, Design, Synthesis and Antifungal Activity Study of Novel Triazole Derivatives